Back to results
Not yet recruitingPhase 2

A Study to Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects with Early Parkinson's Disease

NCT06175767

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Contact

Anandkrishnan Balasubramanian

(301) 956-2531anandb@amarexcro.com
View on ClinicalTrials.gov
A Study to Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects with Early Parkinson's Disease — TrialFind